3B Blackbio DX Ltd (3BBLACKBIO) — share price & stock analysis

Market cap

₹1,031 Cr

P/E

17.6×

ROE

19.8%

vs own 10-yr valuation

56th pctile

Book value / share

₹378

EPS (TTM)

₹67.0

10-yr median P/E

15.4×

Revenue (FY26)

₹142 Cr

Profit after tax (FY26)

₹60 Cr

Weinstein stage

Stage 4 (14 weeks)

Data as of

1 July 2026

4 of the 6 things we track are currently moving the right way — most of the dashboard is turning up.

Where the levels actually stand: ROCE 25% — a high-quality engine; effectively no debt; margins mid-band. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double.

The profits have outrun the price

Since Sept 2017, earnings per share grew 2,092% while the stock is up 1,432%. The business has outrun its own share price.pricettm_eps

When profits grow faster than the price, the stock quietly gets cheaper while doing better — the market hasn’t fully caught up.

Today’s P/E of 17.6× is the middle of its own range against its own 10-year history (56th percentile) — neither a bargain nor a stretch, by its own standards.pe_ratio

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots (the window starts at the first stable snapshot — earlier IPO-era share-count revisions are excluded, since they are not earnings events); between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (15.4×).

The price is in a downtrend — fighting it is expensive

Stock prices move through four repeating stages: basing (1), advancing (2), topping (3) and declining (4). This one is in Stage 4: declining, 14 weeks in, confirmed.stage

The price is below its falling 200-day average — history says most of the damage in stocks happens here. Cheap can get cheaper in Stage 4.dma_200

Trailing NIFTY 500 for 24 weeks — relative strength is the market’s live opinion, and right now it is against it.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

A lumpy ride — no clean trend in profits

Over 12 years, sales went from ₹22.0 Cr to ₹142 Cr (about 17% a year), and profit from ₹0.0 Cr to ₹60.0 Cr.revenuenet_profit

Sales exploded 58% last quarter — the 4th straight quarter of growth

Mar 26 sales were ₹35.4 Cr, up 58% on the same quarter last year.revenue

That makes 4 quarters of growth in a row — this is a trend, not a blip.revenue

Margins are compressing — 35% → 24% in a year

Of every ₹100 of sales, the company keeps ₹24.0 as operating profit (a year ago it kept ₹35.2).opm_pct

The gross margin barely moved (66% → 79%), so the change came from running costs — overheads are growing faster than sales.gpm_pctopm_pct

Profit jumped 22% — mostly from income from outside the core business

Mar 26 profit after tax was ₹9.8 Cr, up 22% year on year.net_profit

A caution: a meaningful slice of this jump came from income outside the core business — that is lower-quality profit and may not repeat.other_income

The profits are real — they turn into cash

Over the last 5 profitable years, the business reported ₹198 Cr of profit and collected ₹182 Cr of operating cash — about 92% conversion.operating_cash_flownet_profit

One asterisk on that strength: suppliers are being paid 42 days later than a year ago (28 → 70 days). Cash flattered by stretching payables is real cash — but it is borrowed timing, not extra earning power.payable_days

The cash cycle is stretching — more money stuck in the pipeline

One rupee now takes about 245 days to go out the door as materials and come back as collected cash — up from 235 days the year before.cash_conversion_cycle

The biggest mover: inventory sitting longer in the warehouse (124 → 187 days).inventory_days

The asset base keeps compounding — this company builds

The productive asset base has gone from ₹4.0 Cr (FY14) to ₹28.0 Cr.fixed_assetscwip

The build is self-funded: the last 3 years' investing outflow (₹77.0 Cr) fits inside the operating cash the business generated (₹122 Cr).investing_cash_flowoperating_cash_flow

Almost no debt — this company cannot be killed by a bad year

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹1 — total borrowings have shrunk from ₹7.0 Cr to ₹3.0 Cr over the window.borrowings

Every ₹100 kept in the business earns ₹25 — a high-quality engine

Return on capital employed is 25.0% (a year ago: 26.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

The owners aren’t moving

Promoters hold 40.9%, essentially unchanged. Foreign funds own 2.6%, domestic funds 2.0%.promoters_pctfiis_pctdiis_pct

Interesting, not obvious

The numbers are genuinely mixed, and the price hasn’t fully caught up with the improvement.

Best thing in the data: free cash flow rising (₹10.0 Cr → ₹28.0 Cr).operating_cash_flow

Biggest worry: margins falling (35.2% → 24.0%).operating_profit

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

Straight answers from the data